tiprankstipranks
IQVIA Holdings Inc (IQV)
NYSE:IQV
US Market

IQVIA Holdings (IQV) Earnings Dates, Call Summary & Reports

Compare
904 Followers

Earnings Data

Report Date
Apr 30, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
2.64
Last Year’s EPS
2.54
Same Quarter Last Year
Based on 19 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Feb 06, 2025
|
% Change Since: -5.56%
|
Next Earnings Date:Apr 30, 2025
Earnings Call Sentiment|Neutral
IQVIA delivered strong results in 2024, with notable achievements in revenue and strategic partnerships, alongside advancements in AI and global health initiatives. However, the significant cancellations and challenging macroeconomic conditions posed considerable hurdles. The outlook remains cautiously optimistic with expected volatility in some segments.
Company Guidance
During the IQVIA fourth quarter 2024 earnings call, the company reported solid financial performance despite challenging market conditions. The company achieved a 5.5% revenue growth at constant currency excluding COVID-related revenues, adjusted diluted earnings per share increased by over 9%, and free cash flow reached $2.1 billion, representing a 41% growth from the previous year. In the fourth quarter alone, the revenue grew by 2.3% on a reported basis and 3% at constant currency, with adjusted diluted earnings per share increasing by 9.9% to $3.12. The R&D Solutions segment experienced net new bookings of over $2.5 billion, and the backlog at year-end stood at $31.1 billion, a 5.5% increase at constant currency compared to the previous year. Additionally, IQVIA reaffirmed its 2025 guidance, anticipating revenue growth of 4% to 7% at constant currency excluding COVID-related impacts, adjusted EBITDA margin expansion of up to 20 basis points, and adjusted diluted earnings per share growth of 5% to 9%.
Solid Full Year Results
IQVIA achieved 5.5% revenue growth at constant currency excluding COVID revenue step down, adjusted diluted EPS growth over 9%, and free cash flow of $2.1 billion, representing a 41% increase.
Strong Operational Performance in Q4
Q4 revenue came in above the high end of guidance with about 4.5% growth excluding foreign exchange and COVID-related work. Adjusted diluted EPS grew nearly 10%, and the quarter achieved a record free cash flow.
Successful Strategic Renewals
IQVIA renewed all large pharma strategic partnerships, expanded existing partnerships, and secured new contracts, positioning the business for future growth.
Advancements in Global Health
IQVIA collaborated with organizations like the World Health Organization to control virus outbreaks, demonstrating its role as a key public health partner.
AI and Digital Innovations
Introduced 60 innovations in 2024, including 39 AI-enabled applications, and expanded digital business into Europe, doubling integrated websites and partners.
Biotech Funding and Pipeline Growth
Biotech funding exceeded $100 billion, a 44% increase from 2023, and the qualified pipeline showed positive growth across all segments.
---

IQVIA Holdings (IQV) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

IQV Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 30, 20252025 (Q1)
2.64 / -
2.54
Feb 06, 20252024 (Q4)
3.11 / 3.12
2.849.86% (+0.28)
Oct 31, 20242024 (Q3)
2.82 / 2.84
2.4914.06% (+0.35)
Jul 22, 20242024 (Q2)
2.56 / 2.64
2.438.64% (+0.21)
May 02, 20242024 (Q1)
2.49 / 2.54
2.453.67% (+0.09)
Feb 14, 20242023 (Q4)
2.82 / 2.84
2.782.16% (+0.06)
Nov 01, 20232023 (Q3)
2.44 / 2.49
2.480.40% (+0.01)
Aug 01, 20232023 (Q2)
2.38 / 2.43
2.44-0.41% (>-0.01)
Apr 27, 20232023 (Q1)
2.41 / 2.45
2.47-0.81% (-0.02)
Feb 10, 20232022 (Q4)
2.76 / 2.78
2.559.02% (+0.23)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

IQV Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 06, 2025$205.44$209.96+2.20%
Oct 31, 2024$216.04$205.82-4.73%
Jul 22, 2024$224.57$245.23+9.20%
May 02, 2024$232.94$222.14-4.64%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does IQVIA Holdings Inc (IQV) report earnings?
IQVIA Holdings Inc (IQV) is schdueled to report earning on Apr 30, 2025, TBA Not Confirmed.
    What is IQVIA Holdings Inc (IQV) earnings time?
    IQVIA Holdings Inc (IQV) earnings time is at Apr 30, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is IQV EPS forecast?
          IQV EPS forecast for the fiscal quarter 2025 (Q1) is 2.64.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis